3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
93
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
13
Rectal Neoplasms
10
Colorectal Neoplasms
10
Stomach Neoplasms
3
Biliary Tract Neoplasms
2
Triple Negative Breast Neoplasms
1
Solid Tumor
1
Recurrence
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Neoplasm Metastasis
1
Microbiota
1
Gallbladder Neoplasms
1
Fruquintinib
1
Elderly Metastatic Colorectal Cancer Patients
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Breast Cancer Organoids
1
Breast Cancer Metastatic
1
Brain Neoplasms
1
Ampullary Adenocarcinoma
1
Interventions
Surveys and Questionnaires
11
Blood Specimen Collection
10
Colonoscopy
8
Psychiatric Rehabilitation
7
Immunohistochemistry
6
Drug Therapy
6
Biopsy
6
Polymerase Chain Reaction
5
Mental Status and Dementia Tests
5
Surgical Procedures, Operative
4
Observation
4
Immunoenzyme Techniques
4
Gene Expression Profiling
4
Endoscopic Mucosal Resection
4
Colectomy
4
Amplified Fragment Length Polymorphism Analysis
4
Watchful Waiting
3
Polyethylene Glycols
3
Microarray Analysis
3
Magnetic Resonance Spectroscopy
3
Laparoscopy
3
Genetic Testing
3
Exercise
3
Endoscopy
3
Chromosome Mapping
3
Bevacizumab
3
Specimen Handling
2
Reverse Transcriptase Polymerase Chain Reaction
2
Radiotherapy
2
Mass Spectrometry
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Colonic Neoplasms
×
Capecitabine
×
Clear all
NCT02479217
2017-02-17
Safety of Xeloda in Solid Tumours
Hoffmann-La Roche
Completed
1,268 enrolled